| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |